|
Galena Biopharma Reports First Quarter 2015 Financial Results
CNNMoney On March 18, 2015, we announced the closing of our underwritten public offering of 24,358,974 shares of common stock and 12,179,487 warrants to purchase our common stock at an exercise price of $2.08. The underwriters also exercised their … |
